Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Heart Test Laboratories Q3 EPS $(0.16) Beats $(0.22) Estimate, Sales $1.95K

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.22) by 27.27 percent. The company reported $1.95 thousand in sales this quarter.
byMichael Horton
March 16, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.22) by 27.27 percent. The company reported $1.95 thousand in sales this quarter.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Reported Late Wednesday, DZS Announces Pricing Of ~$28.8M Public Offering Of ~3,377,315 Shares At A Price Of $11.50/Share; 2,507,750 Shares Are Being Offered By The Company And 869,565 Shares Are Being Offered By The Selling Stockholder

By Benzinga Newsdesk
November 17, 2:07 AM
DZS Inc. (NASDAQ:DZSI) (the "Company" or "DZS"), a global leader in access and optical edge infrastructure and cloud software solutions, today announced that it has priced an underwritten registered

DZSI

Read More

Sorry Aaron Rodgers, But Lamar Jackson Could Become The Highest Paid Quarterback In The NFL

By Robert Kuczmarski
September 13, 1:56 PM
Former Heisman Trophy winner Lamar Jackson signed with the Baltimore Ravens as the final first-round draft pick in the 2018 NFL draft. When Jackson first signed with the Ravens, he entered into a four-year contract for approximately $9.5 million with signing bonuses included and a fifth-year exercisable option for a base salary of $23 million in 2022.

DKNG